MUMBAI: Dilip Shanghvi’s shrinking fortune has become one of the most visible casualties of the troubles hitting India’s generic drug industry. Once India’s richest person, he recently slipped to No. 6 with his fortune dropping US$14.1bil from its peak of about two years ago.
The founder and head of Sun Pharmaceutical Industries Ltd has seen his net worth fall to US$11.1bil on the Bloomberg Billionaires Index, as shares of India’s largest drug maker tumbled 56% from its all-time high in April 2015.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
